83 selected items - PubMed - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

<< First< Prev

Page of 5

Results: 1 to 20 of 83

1.

New strategies in melanoma: molecular testing in advanced disease.

Woodman SE, Lazar AJ, Aldape KD, Davies MA.

Clin Cancer Res. 2012 Mar 1;18(5):1195-200. Epub 2012 Jan 24.

PMID:: 22275506; [PubMed - in process]

Related citations

2.

CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.

Prieto PA, Yang JC, Sherry RM, Hughes MS, Kammula US, White DE, Levy CL, Rosenberg SA, Phan GQ.

Clin Cancer Res. 2012 Apr 1;18(7):2039-47. Epub 2012 Jan 23.

PMID:: 22271879; [PubMed - in process]

Related citations

3.

Rehabilitation for oncogene addiction: role of immunity in cellular sobriety.

Bajor DL, Vonderheide RH.

Clin Cancer Res. 2012 Mar 1;18(5):1192-4. Epub 2012 Jan 20.

PMID:: 22266272; [PubMed - in process]

Related citations

4.

Sunitinib therapy for melanoma patients with KIT mutations.

Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC.

Clin Cancer Res. 2012 Mar 1;18(5):1457-63. Epub 2012 Jan 18.

PMID:: 22261812; [PubMed - in process]

Related citations

5.

Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).

Margolin KA, Moon J, Flaherty LE, Lao CD, Akerley WL 3rd, Othus M, Sosman JA, Kirkwood JM, Sondak VK.

Clin Cancer Res. 2012 Feb 15;18(4):1129-37. Epub 2012 Jan 6.

PMID:: 22228638; [PubMed - in process]

Related citations

6.

Notch signaling promotes growth and invasion in uveal melanoma.

Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG.

Clin Cancer Res. 2012 Feb 1;18(3):654-65. Epub 2012 Jan 6.

PMID:: 22228632; [PubMed - indexed for MEDLINE]

Related citations

7.

Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma.

Davies MA, Fox PS, Papadopoulos NE, Bedikian AY, Hwu WJ, Lazar AJ, Prieto VG, Culotta KS, Madden TL, Xu Q, Huang S, Deng W, Ng CS, Gupta S, Liu W, Dancey JE, Wright JJ, Bassett RL, Hwu P, Kim KB.

Clin Cancer Res. 2012 Feb 15;18(4):1120-8. Epub 2012 Jan 5.

PMID:: 22223528; [PubMed - in process]

Related citations

8.

BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance.

Alcalá AM, Flaherty KT.

Clin Cancer Res. 2012 Jan 1;18(1):33-9.

PMID:: 22215904; [PubMed - indexed for MEDLINE]

Related citations

9.

Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.

Lucas KM, Mohana-Kumaran N, Lau D, Zhang XD, Hersey P, Huang DC, Weninger W, Haass NK, Allen JD.

Clin Cancer Res. 2012 Feb 1;18(3):783-95. Epub 2011 Dec 15.

PMID:: 22173547; [PubMed - indexed for MEDLINE]

Related citations

10.

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.

Wilmott JS, Long GV, Howle JR, Haydu LE, Sharma RN, Thompson JF, Kefford RF, Hersey P, Scolyer RA.

Clin Cancer Res. 2012 Mar 1;18(5):1386-94. Epub 2011 Dec 12.

PMID:: 22156613; [PubMed - in process]

Related citations

11.

New challenges in endpoints for drug development in advanced melanoma.

Ribas A, Hersey P, Middleton MR, Gogas H, Flaherty KT, Sondak VK, Kirkwood JM.

Clin Cancer Res. 2012 Jan 15;18(2):336-41. Epub 2011 Dec 5.

PMID:: 22142824; [PubMed - in process]

Related citations

12.

Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.

Xu X, Chen L, Guerry D, Dawson PR, Hwang WT, VanBelle P, Elder DE, Zhang PJ, Ming ME, Schuchter L, Gimotty PA.

Clin Cancer Res. 2012 Jan 1;18(1):229-37. Epub 2011 Nov 17.

PMID:: 22096024; [PubMed - indexed for MEDLINE]

Related citations

13.

Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma.

Luke JJ, Hodi FS.

Clin Cancer Res. 2012 Jan 1;18(1):9-14. Epub 2011 Nov 14.

PMID:: 22083257; [PubMed - indexed for MEDLINE]

Related citations

14.

Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.

Kirkwood JM, Bastholt L, Robert C, Sosman J, Larkin J, Hersey P, Middleton M, Cantarini M, Zazulina V, Kemsley K, Dummer R.

Clin Cancer Res. 2012 Jan 15;18(2):555-67. Epub 2011 Nov 2.

PMID:: 22048237; [PubMed - in process]

Related citations

15.

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.

Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW.

Clin Cancer Res. 2012 Jan 15;18(2):408-16. Epub 2011 Oct 28.

PMID:: 22038994; [PubMed - in process]

Related citations

16.

A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.

Eigentler TK, Weide B, de Braud F, Spitaleri G, Romanini A, Pflugfelder A, González-Iglesias R, Tasciotti A, Giovannoni L, Schwager K, Lovato V, Kaspar M, Trachsel E, Menssen HD, Neri D, Garbe C.

Clin Cancer Res. 2011 Dec 15;17(24):7732-42. Epub 2011 Oct 25.

PMID:: 22028492; [PubMed - in process]

Related citations

17.

Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.

Chen P, Huang Y, Bong R, Ding Y, Song N, Wang X, Song X, Luo Y.

Clin Cancer Res. 2011 Dec 1;17(23):7230-9. Epub 2011 Oct 12.

PMID:: 21994414; [PubMed - indexed for MEDLINE]

Related citations

18.

Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, in patients with metastatic melanoma.

Fruehauf J, Lutzky J, McDermott D, Brown CK, Meric JB, Rosbrook B, Shalinsky DR, Liau KF, Niethammer AG, Kim S, Rixe O.

Clin Cancer Res. 2011 Dec 1;17(23):7462-9. Epub 2011 Oct 5.

PMID:: 21976544; [PubMed - indexed for MEDLINE]

Related citations

19.

Phase I/II and pharmacodynamic study of dovitinib (TKI258), an inhibitor of fibroblast growth factor receptors and VEGF receptors, in patients with advanced melanoma.

Kim KB, Chesney J, Robinson D, Gardner H, Shi MM, Kirkwood JM.

Clin Cancer Res. 2011 Dec 1;17(23):7451-61. Epub 2011 Oct 5.

PMID:: 21976540; [PubMed - indexed for MEDLINE]

Related citations

20.

Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.

Weiss GR, Grosh WW, Chianese-Bullock KA, Zhao Y, Liu H, Slingluff CL Jr, Marincola FM, Wang E.

Clin Cancer Res. 2011 Dec 1;17(23):7440-50. Epub 2011 Oct 5.

PMID:: 21976537; [PubMed - indexed for MEDLINE]

Related citations

<< First< Prev

Page of 5

Supplemental Content

Filters: Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

New strategies in melanoma: molecular testing in advanced disease.
New strategies in melanoma: molecular testing in advanced disease.
Clin Cancer Res. 2012 Mar 1 ;18(5):1195-200. Epub 2012 Jan 24 .

PubMed
Human Parietofrontal Networks Related to Action Observation Detected at Rest.
Human Parietofrontal Networks Related to Action Observation Detected at Rest.
Cereb Cortex. 2012 Jan 23. [Epub ahead of print]

PubMed
Comment on: Wehr et al. Low free testosterone levels are associated with all-cau...
Comment on: Wehr et al. Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care 2011;34:1771-1777.
Diabetes Care. 2012 Feb ;35(2):e9; author reply e10.

PubMed
Genetic risk assessment of type 2 diabetes-associated polymorphisms in African A...
Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans.
Diabetes Care. 2012 Feb ;35(2):287-92.

PubMed
Re: inconsistencies in findings from the early lung cancer action project studie...
Re: inconsistencies in findings from the early lung cancer action project studies of lung cancer screening.
J Natl Cancer Inst. 2012 Feb 8 ;104(3):254-5; author reply 255-6. Epub 2012 Jan 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk